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Among the many factors contributing to aging, one of 
the most highly investigated focuses on the theory that 
there is a gradually decline of mitochondrial function 
with age leading to progressive tissue damage via 
oxidative stress (Figure 1, right). Indeed, proper 
mitochondrial function is required for normal 
metabolism and health at multiple levels. Mutations in 
mitochondrial DNA (mtDNA) result in a variety of 
phenotypes including myopathies, neuropathies, 
diabetes, signs of premature aging and reduced lifespan 
[1,2]. Mitochondrial dysfunction in the absence of 
somatic mutations is also a feature of normal aging and 
has been observed in species ranging from worms to 
humans.  At the organ level, mitochondrial dysfunction 
occurs in many age-related diseases, including type 2 
diabetes and obesity.  In both rodents and humans, 
obesity and type 2 diabetes are associated reduced 
expression of mtDNA and reduced levels of proteins 
involved in oxidative phosphorylation in muscle, liver 
and adipose tissue [3]. Conversely, caloric restriction, 
which increases mitochondria biogenesis and maintains 
mitochondrial function, is associated with increased 
longevity [2]. 
 
Over the past few years, a number of studies have 
appeared which challenge the mitochondrial theory of 
aging. Indeed, mutations in genes involved in the 
electron transport chain that cause mitochondrial 
dysfunction can sometimes paradoxically lead to 
improved health and/or enhanced longevity [4]. One 
example is the situation in mice with conditional 
knockout of the mitochondrial transcription factor A 
(TFAM) specifically in fat. These F-TFKO mice exhibit 
mitochondrial dysfunction with increased energy 
expenditure, but are protected from age- and diet-
induced obesity, insulin resistance and hepatosteatosis, 
despite increased food intake [5].  
 
Mitochondrial DNA (mtDNA) is maternally inherited 
with multiple copies in each mitochondria. TFAM plays 
a critical role in maintenance and expression of 
mtDNA, and reductions of mtDNA copy number 
usually correlate with reduction of mitochondria content 
and function. So, how does a reduction in TFAM in fat 
have this beneficial effect?  
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First, despite the reduction in TFAM levels, there is no 
significant difference in mitochondria number in brown 
and white adipose tissue between control and F-TFAM 
KO. Reduction of TFAM, however, does result in 
decreased mtDNA copy number and altered levels of 
proteins of the electron transport chain. This in turn 
results in decreased Complex I activity, greater oxygen 
consumption and increased uncoupled respiration. As a 
result, the mitochondrial oxidative capacity of the 
adipose tissue is increased and outpaces metabolic flux 
through the TCA cycle, but in mice on a normal chow 
diet this occurs without indication of oxidative stress or 
damage (Figure 1, left).  
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Figure 1. Adipose tissue mitochondria dysfunction protects
against  obesity  and  aging‐related  diseases.  In  TFAM  KO
adipose tissue, the combination of a decrease in Complex I activity
with an increase of uncoupling state creates a mild mitochondria
dysfunction  without  oxidative  stress  (Left).  Upon  high  fat  diet
stress, adipose tissue mitochondria are overloaded, but adipose
tissue mass remains small and insulin sensitive, despite signs of
oxidative stress (Middle). Finally, severe mitochondria dysfunction
is known to trigger high level of oxidative stress damage, impairs
cellular  function  and  promotes  aged‐related  disorders  such  as
insulin resistance (Right). 
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KO mice develop a build-up of long chain acyl 
carnitines in both adipose tissue and the circulation. In 
addition, markers of oxidative stress are observed at the 
level of DNA and lipids in adipose tissue of F-TFKO 
mice on high fat diet, indicating overload of the ROS 
protection system (Figure 1, center). Despite this 
mitochondria stress, the mice remain lean and insulin 
sensitive even at 10 months of age. Although no formal 
aging studies have been conducted in these mice, we 
also noted that by 18 months of age, an age at which the 
control mice have started to die, the F-TFKO mice are 
still thriving, suggesting this knockout may be 
beneficial to aging mice as well.  
 
White adipose tissue contributes to lipid storage and 
thermoregulation but is also a critical endocrine organ. 
In classical endocrine tissues like pancreatic β−cells, 
mitochondrial dysfunction results in altered insulin 
secretion and diabetes [3]. In normal lean mice, high 
levels of adiponectin secretion by adipose tissue are 
associated with healthy aging and longevity by 
promoting insulin sensitivity and protecting the heart 
[6]. Interestingly, although adiponectin mRNA 
expression is increased in white fat of F-TFKO mice 
consistent with decreased fat mass, circulating 
adiponectin levels are reduced by almost 50%.  This is 
because adiponectin peptides undergo multimerization 
within the ER of adipocytes prior to secretion, and this 
process can be impaired if mitochondrial activity is 
reduced and/or uncoupled. While low adiponectin levels 
in this setting do not appear to promote insulin 
resistance, cardiac function in the F-TFKO mice has not 
yet been studied. 
 
Strategies to combat obesity, improve insulin sensitivity 
and potentially increase longevity include decreasing 
white adipose tissue mass, increasing brown adipose 
tissue mass and increasing “browning” of white adipose 
tissue [7]. In both of the latter situations, there is an 
overall increase in mitochondrial activity. By contrast, 
in F-TFKO mice, both white and brown fat mass are 
reduced and there is no significant “browning” of the 
white adipose tissue. However, in this setting, 
increasing mitochondria oxidation in fat has positive 
metabolic effects that protect mice from obesity, insulin 
resistance and related pathologies. Whether agents that 
reduce TFAM level and/or activity or Complex I 
activity in adipose tissue will reduce of aged related 
diseases and enhance lifespan remains to be determined. 
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